Article Details
Retrieved on: 2021-07-06 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche licensed the treatment candidate from Ionis in 2017. An independent monitoring committee didn't find safety issues but cited the "potential benefit/ ...
Article found on: www.fool.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here